Skip to main content
TipRanks
Go Ultimate75% OFF

Everest Medicines Ltd. (1952) Ownership - Who Owns Everest Medicines Ltd.?

5 Followers

Everest Medicines Ltd. (1952) Ownership Overview

  • 2.62% Mutual Funds
  • 4.80% ETFs
  • 92.58% Public Companies and Individual Investors

The ownership structure of Everest Medicines Ltd. (HK:1952) stock is a mix of institutional, retail, and individual investors. Approximately 7.42% of the company’s stock is owned by Institutional Investors, and 92.58% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

HK:1952 top shareholders
Holder# of SharesType% HoldingValue
Vanguard8,956,226Institution2.53%29,958,576
Ishares6,102,886Institution1.72%20,414,154
Vanguard International Equity Index Funds5,183,500Institution1.46%17,338,808
Vanguard Star Funds3,830,112Institution1.08%12,811,725
State Street1,433,500Institution0.40%4,795,058
Dimensional355,500Institution0.10%1,189,148
Fidelity Salem Street Trust154,019Institution0.04%515,194
Spdr112,000Institution0.03%374,640
State Street Institutional Investment Trust73,000Institution0.02%244,185
Dfa Investment Dimensions Group Inc57,000Institution0.02%190,665

Top Mutual Fund Holders

HK:1952 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard International Equity Index Funds5,183,500Institution1.46%17,338,808
Vanguard Star Funds3,830,112Institution1.08%12,811,725
Fidelity Salem Street Trust154,019Institution0.04%515,194
State Street Institutional Investment Trust73,000Institution0.02%244,185
Dfa Investment Dimensions Group Inc57,000Institution0.02%190,665

Top ETF Holders

HK:1952 top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total International Stock ETF, VXUS ETF3,908,612Institution1.10%14,948,544
Vanguard FTSE Emerging Markets ETF, VWO ETF3,763,000Institution1.06%14,391,648
iShares Core MSCI Emerging Markets ETF, IEMG ETF3,301,000Institution0.93%10,981,044
SPDR Portfolio Emerging Markets ETF, SPEM ETF1,220,500Institution0.34%4,181,878
Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF985,000Institution0.28%3,767,145
iShares Core MSCI Total International Stock ETF, IXUS ETF245,000Institution0.07%815,012
Vanguard Total World Stock ETF, VT ETF221,500Institution0.06%847,130
SPDR S&P Emerging Markets Small Cap ETF, EWX ETF157,000Institution0.04%537,939
iShares MSCI EM IMI ESG Screened UCITS ETF, GB:SEDM ETF154,500Institution0.04%529,373
Dimensional Emerging Core Equity Market ETF, DFAE ETF152,500Institution0.04%522,521

FAQ

What percentage of Everest Medicines Ltd. (HK:1952) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.42% of Everest Medicines Ltd. (HK:1952) stock is held by institutional investors: 2.62% by mutual funds and 4.80% by ETFs.
What percentage of Everest Medicines Ltd. (HK:1952) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.58% of Everest Medicines Ltd. (HK:1952) stock is held by public companies and individual investors.
Who owns the most shares of Everest Medicines Ltd. (HK:1952)?
Vanguard owns the most shares of Everest Medicines Ltd. (HK:1952).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.